sulfur burps and diarrhea glp 1 Sulphur from GLP-1 Injections (Mounjaro, Wegovy): How to Manage Them Sulfur burps on GLP-1 medications:

The trial found that after 5 years, Wegovy significantly reduced the risk of death from heart disease by 15% and reduced the risk of cardiovascular events including nonfatal heart attacks and strokes by 20%, compared to an inactive placebo

They improve insulin sensitivity, lower HbA1c, reduce blood pressure, and improve lipid profiles

Sedentary lifestyle & poor sleep Chronic inactivity and disrupted sleep patterns can negatively affect gut-brain communication and may reduce the effectiveness of natural GLP-1 release and appetite regulation

Impact of GLP-1 receptor agonists on cardiovascular outcomes in heart failure with preserved ejection fraction (HFpEF): systematic review and meta-analysis

Semaglutide (Ozempic and Wegovy) Semaglutide is the most widely used GLP-1 receptor agonist for weight loss

Funding Open access funding provided by Universit degli Studi di Brescia within the CRUI-CARE Agreement